|
Volumn 19, Issue 2, 2004, Pages 120-129
|
CYP3A5 Contributes significantly to CYP3A-mediated drug oxidations in liver microsomes from Japanese subjects.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE RECEPTOR AFFECTING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CYP3A PROTEIN, HUMAN;
CYP3A4 PROTEIN, HUMAN;
CYP3A5 PROTEIN, HUMAN;
CYTOCHROME P450;
DILTIAZEM;
DNA;
DRUG;
MIDAZOLAM;
PRIMER DNA;
REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE FERRIHEMOPROTEIN REDUCTASE;
TESTOSTERONE;
ARTICLE;
DEALKYLATION;
ENZYMOLOGY;
ESCHERICHIA COLI;
GENETICS;
GENOTYPE;
HUMAN;
HYDROXYLATION;
IN VITRO STUDY;
JAPAN;
KINETICS;
LIVER MICROSOME;
METABOLISM;
OXIDATION REDUCTION REACTION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
CALCIUM CHANNEL BLOCKERS;
CYTOCHROME P-450 ENZYME SYSTEM;
DEALKYLATION;
DILTIAZEM;
DNA;
DNA PRIMERS;
ESCHERICHIA COLI;
GABA MODULATORS;
GENOTYPE;
HUMANS;
HYDROXYLATION;
JAPAN;
KINETICS;
MICROSOMES, LIVER;
MIDAZOLAM;
NADPH-FERRIHEMOPROTEIN REDUCTASE;
OXIDATION-REDUCTION;
PHARMACEUTICAL PREPARATIONS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
TESTOSTERONE;
|
EID: 4644263308
PISSN: 13474367
EISSN: None
Source Type: Journal
DOI: 10.2133/dmpk.19.120 Document Type: Article |
Times cited : (49)
|
References (0)
|